Kisspeptin – Comprehensive Research Overview (2026)

Kisspeptin is a naturally occurring neuropeptide encoded by the KISS1 gene, acting as the master regulator of the hypothalamic-pituitary-gonadal (HPG) axis. It stimulates GnRH release, which drives LH and FSH secretion, making it the upstream gatekeeper of reproductive hormone function. Kisspeptin is researched for hypogonadism, infertility, sexual dysfunction, and puberty disorders. It also plays roles in metabolic regulation and mood.

→ View Kisspeptin (for laboratory research use only)

Mechanism of Action

  • Binds KISS1R (GPR54) receptors on GnRH neurons in the hypothalamus.
  • Stimulates pulsatile GnRH release → LH and FSH secretion from the pituitary.
  • Drives testosterone production in males and estrogen/progesterone in females.
  • Modulates sexual behavior, mood, and metabolic signaling via central pathways.
  • Kisspeptin-10 (the C-terminal decapeptide) is the most active and studied fragment.

Clinical Evidence and Research Findings

Multiple human clinical trials demonstrate that exogenous kisspeptin robustly stimulates LH, FSH, and sex steroid secretion in both healthy volunteers and patients with hypogonadotropic hypogonadism. It has been studied for male and female infertility, hypothalamic amenorrhea, and sexual dysfunction. Kisspeptin also shows signals for improving mood and reducing sexual aversion in clinical research.

→ Interested in researching Kisspeptin? View Product Options

Benefits (Research & Clinical Observations)

  • Stimulation of LH, FSH, and sex steroid production
  • Support for hypogonadotropic hypogonadism research
  • Potential for infertility and reproductive endocrinology research
  • Mood and sexual function modulation
  • Metabolic regulatory effects

Typical Dosing Protocols (Research)

  • Clinical research doses: 0.3–3.2 nmol/kg IV bolus or subcutaneous
  • Off-label protocols: 50–100 μg subcutaneous once or twice daily
  • Pulsatile administration mimics physiologic GnRH signaling more effectively than continuous infusion

Safety Profile and Side Effects

Kisspeptin has a favorable safety profile in clinical trials. Common side effects: mild flushing, transient LH surge effects. No significant adverse events at research doses.

Summary

Kisspeptin is the master upstream regulator of reproductive hormone function with robust clinical evidence for HPG axis stimulation. Its unique position in the endocrine cascade makes it a valuable research tool for hypogonadism, infertility, and sexual health. As with all compounds in this library, Kisspeptin is not an approved drug and should only be considered under qualified medical supervision.

For Laboratory Research Use View Kisspeptin →

Disclaimer This overview is strictly educational and based on publicly available scientific literature as of April 2026. It does not constitute medical advice. Always consult a qualified healthcare professional and comply with all applicable laws and regulations.